Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.47 |
| ▸ | GRM5 | P41594 | 1/20 | 0.40 |
| ▸ | ASIC3 | Q9UHC3 | 2/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 4/20 | 0.35 |
| ▸ | MAPKAPK2 | P49137 | 3/20 | 0.35 |
| ▸ | JAK2 | O60674 | 2/20 | 0.35 |
| ▸ | HTR7 | P34969 | 1/20 | 0.35 |
| ▸ | PIM1 | P11309 | 1/20 | 0.34 |
| ▸ | SRC | P12931 | 1/20 | 0.34 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.34 |
| ▸ | CTSS | P25774 | 1/20 | 0.33 |
| ▸ | CTSK | P43235 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17234420 | 0.83 | ATP1A1 (0.45) | ASIC3MAPKAPK2TGFBR1 | |
| SCHEMBL17426496 | 0.81 | TGFBR1 (0.43) | BRD4GRM5ASIC3CYP2A6MAPKAPK2 | |
| SCHEMBL14054103 | 0.79 | ASIC3 (0.53) | ASIC3CYP2A6MAPKAPK2HTR7PIM1 | |
| SCHEMBL17426498 | 0.78 | IDO1 (0.41) | GRM5CTSSCTSK | |
| SCHEMBL2609361 | 0.78 | PIM1 (0.48) | GRM5MAPKAPK2PIM1TGFBR1 | |
| SCHEMBL15340927 | 0.78 | LDHB (0.49) | PIM1 | |
| Hydrochloric Acid SCHEMBL28148517 | 0.77 | ASIC3 (0.52) | ASIC3CYP2A6MAPKAPK2HTR7PIM1 | |
| SCHEMBL23879668 | 0.77 | LMNA (0.49) | PIM1TGFBR1 | |
| SCHEMBL24358706 | 0.76 | RXRA (0.55) | — | |
| SCHEMBL25456048 | 0.76 | ASIC3 (0.50) | ASIC3MAPKAPK2HTR7TGFBR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11139443-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2021-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11139443-B2 | Organic electroluminescent materials and devices | ICOSLG, ORC3, OR10J3 | BRD4 964/4885GRM5 647/4885ASIC3 484/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.